Compare
Agencia Comercial Spirits Ltd. vs Epsium Enterprise Ltd vs Marwynn Holdings, Inc. vs VitaNova Life Sciences Corp
| Latest fiscal year | Agencia Comercial Spirits Ltd. AGCC | Epsium Enterprise Ltd EPSM | Marwynn Holdings, Inc. MWYN | VitaNova Life Sciences Corp VNOV |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-04-30 | 2026-04-30 |
| Revenue | $6.21M | $5.12M | $4.24M | $3.03M |
| Revenue growth (YoY) | +144.6% | -59.1% | +427.5% | +13.7% |
| Gross margin | 30.4% | 14.7% | 15.3% | 30.1% |
| Operating margin | 12.6% | -29.2% | -77.3% | 0.1% |
| Net margin | 9.8% | -29.3% | -92.4% | -1.2% |
| Net income | $609.4K | -$1.50M | -$3.92M | -$37.3K |
| EPS (Diluted) | $0.0383 | n/a | -$0.21 | n/a |
| Operating cash flow | -$7.50M | -$2.38M | -$1.55M | $814.4K |
| Free cash flow | n/a | -$2.38M | n/a | n/a |
| Cash & equivalents | $15.82M | n/a | $152.2K | n/a |
| Total assets | $28.22M | $13.30M | $3.01M | $2.45M |
| Total liabilities | $18.35M | $1.82M | $428.0K | $395.8K |
| Shareholders' equity | $9.87M | $11.48M | $2.58M | $2.05M |
| Return on year-end equity | 6.2% | -13.0% | -151.8% | -1.8% |
| Shares outstanding | n/a | n/a | 20.19M | 8.34M |
Revenue, most recent five fiscal years
| Fiscal year | Agencia Comercial Spirits Ltd. | Epsium Enterprise Ltd | Marwynn Holdings, Inc. | VitaNova Life Sciences Corp |
|---|---|---|---|---|
| Latest | $6.21M Ended 2025-12-31 | $5.12M Ended 2025-12-31 | $4.24M Ended 2026-04-30 | $3.03M Ended 2026-04-30 |
| 1 year earlier | $2.54M Ended 2024-12-31 | $12.52M Ended 2024-12-31 | $804.3K Ended 2025-04-30 | $2.66M Ended 2025-04-30 |
| 2 years earlier | $887.3K Ended 2023-12-31 | $29.20M Ended 2023-12-31 | $11.92M Ended 2024-04-30 | $570.7K Ended 2024-04-30 |
| 3 years earlier | n/a | $11.17M Ended 2022-12-31 | n/a | $38.0K Ended 2023-04-30 |
| 4 years earlier | n/a | n/a | n/a | $120.0K Ended 2022-04-30 |